Michael C Roy

Title: Innovations by Michael C Roy

Introduction

Michael C Roy is an accomplished inventor based in Groton, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled-release oral dosage forms. With a total of 2 patents to his name, Roy's work focuses on reducing nicotine addiction and improving drug delivery systems.

Latest Patents

One of Roy's latest patents is directed towards controlled-release (CR) oral pharmaceutical dosage forms of 5,8,14-triazatetracyclo[10.3.1.00]-hexadeca-2(11),3,5,7,9-pentaene, and its pharmaceutically acceptable salts. This invention aims to aid in the cessation of tobacco use while minimizing nausea as an adverse effect. Another notable patent involves a hydrogel-driven layered drug dosage form for sertraline, which features a core comprising a sertraline-containing composition and a water-swellable composition. This innovative dosage form is designed to release sertraline at a controlled rate, ensuring effective treatment over time.

Career Highlights

Michael C Roy is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to further his research and development efforts in the pharmaceutical industry, contributing to advancements in drug formulations and delivery systems.

Collaborations

Throughout his career, Roy has collaborated with notable colleagues, including Kenneth C Waterman and William John Curatolo. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical technologies.

Conclusion

Michael C Roy's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving drug delivery and reducing addiction. His work continues to impact the industry positively, paving the way for future advancements.